MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma
Autor: | Nymoen, Dag Andre, Slipicevic, Ana, Holth, Arild, Emilsen, Elisabeth, Hetland Falkenthal, Thea E., Tropé, Claes G., Reich, Reuven, Flørenes, Vivi Ann, Davidson, Ben |
---|---|
Zdroj: | In Human Pathology August 2016 54:74-81 |
Databáze: | ScienceDirect |
Externí odkaz: |